Publications by authors named "Mei La"

Claim this Profile
D
Diagnostic Value and Prognostic Significance of Procalcitonin Combined with C-Reactive Protein in Patients with Bacterial Bloodstream Infection.
Yan Zhang, Mei La, Jihong Sun, Mimi Chen, Dandan Liu

Comput Math Methods Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A method to switch from oral dopamine agonists to rotigotine in patients with restless legs syndrome and mild augmentation.
John W Winkelman, Susan E Mackie, Leslie A Mei, Samuel Platt, Laura Schoerning

Sleep Med· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel-loaded PEG-PE-based micellar nanopreparations targeted with tumor-specific landscape phage fusion protein enhance apoptosis and efficiently reduce tumors.
Tao Wang, Shenghong Yang, Leslie A Mei, Chirag K Parmar, James W Gillespie, Vladimir P Torchilin

Mol Cancer Ther· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced tumor delivery and antitumor activity in vivo of liposomal doxorubicin modified with MCF-7-specific phage fusion protein.
Tao Wang, William C Hartner, James W Gillespie, Kulkarni P Praveen, Shenghong Yang, Vladimir P Torchilin

Nanomedicine· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline genetic variation and treatment response on CCG-1891.
Dana M Sepe, Thomas McWilliams, Jinbo Chen, Aaron Kershenbaum, Huaqing Zhao, Mei La, Beverly Lange

Pediatr Blood Cancer· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Yousif Matloub, Bruce C Bostrom, Stephen P Hunger, Linda C Stork, Anne Angiolillo, Harland Sather, Mei La, Nyla A Heerema

Blood· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postrelapse survival in childhood acute lymphoblastic leukemia is independent of initial treatment intensity: a report from the Children's Oncology Group.
David R Freyer, Meenakshi Devidas, Mei La, William L Carroll, Paul S Gaynon

Blood· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology Group.
ZoAnn E Dreyer, Patricia A Dinndorf, Bruce Camitta, Harland Sather, Mei K La, Nyla A Heerema

J Clin Oncol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial.
Linda C Stork, Yousif Matloub, Emmett Broxson, Mei La, Rochelle Yanofsky, Harland Sather, Nyla A Heerema

Blood· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group.
James B Nachman, Mei K La, Stephen P Hunger, Nyla A Heerema, Paul S Gaynon, Harland Sather

J Clin Oncol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies.
Wendy Stock, Mei La, Ben Sanford, Clara D Bloomfield, James W Vardiman, Richard A Larson

Blood· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Nita L Seibel, Peter G Steinherz, Harland N Sather, James B Nachman, Cynthia Delaat, Lawrence J Ettinger, Nyla A Heerema, Allan F Pyesmany, Mei K La

Blood· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children's Oncology Group study CCG-1952.
Suman Malempati, Paul S Gaynon, Harland Sather, Mei K La, Linda C Stork

J Clin Oncol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group.
Yousif Matloub, Susan Lindemulder, Paul S Gaynon, Harland Sather, Mei La, Nyla A Heerema, Marilyn Blake

Blood· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous 6-mercaptopurine decreases salvage after relapse in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group study CCG 1922.
Jakub Tolar, Bruce C Bostrom, Mei K La, Harland N Sather

Pediatr Blood Cancer· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic significance of P-glycoprotein, multidrug resistance-related protein 1 and lung resistance protein in pediatric acute lymphoblastic leukemia: a retrospective study of 295 newly diagnosed patients by the Children's Oncology Group.
Douglas P Olson, Barbara J Taylor, Mei La, Harland Sather, Gregory H Reaman

Leuk Lymphoma· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia.
Richard Aplenc, Jennifer Thompson, Peggy Han, Mei La, Huaqing Zhao, Beverly Lange

Cancer Res· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952.
Mylène Bassal, Mei K La, James A Whitlock, Harland N Sather, Nyla A Heerema

Pediatr Blood Cancer· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961.
Eduard H Panosyan, Nita L Seibel, Sagrario Martin-Aragon, Paul S Gaynon, Ioannis A Avramis, Harland Sather, Lawrence J Ettinger, Mei La

J Pediatr Hematol Oncol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced folate carrier and dihydrofolate reductase expression in acute lymphocytic leukemia may predict outcome: a Children's Cancer Group Study.
Adam S Levy, Harland N Sather, Peter G Steinherz, Rebecca Sowers, Mei La

J Pediatr Hematol Oncol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYP3A genotypes and treatment response in paediatric acute lymphoblastic leukaemia.
Richard Aplenc, Wendy Glatfelter, Peggy Han, Eric Rappaport, Mei La, M Anne Blackwood, Beverly Lange

Br J Haematol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Bruce C Bostrom, Martha R Sensel, Harland N Sather, Paul S Gaynon, Mei K La, Nyla A Heerema

Blood· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Beverly J Lange, Bruce C Bostrom, Joel M Cherlow, Martha G Sensel, Mei K L La, Nyla A Heerema, Harland N Sather

Blood· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abnormalities of chromosome bands 15q13-15 in childhood acute lymphoblastic leukemia.
Nyla A Heerema, Harland N Sather, Martha G Sensel, Mei K L La, Raymond J Hutchinson, Beverly J Lange

Cancer· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis